 | • レポートコード：QYR9ST04897 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、特発性肺線維症の世界市場について調査・分析し、特発性肺線維症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（全身性コルチコステロイド、免疫抑制薬、チロシンキナーゼ阻害剤、抗線維化剤）、用途別（病院、診療所、外来手術センター、学術研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の特発性肺線維症市場動向 ・主要企業別マーケットシェア ・特発性肺線維症の種類別市場規模2014-2019 （全身性コルチコステロイド、免疫抑制薬、チロシンキナーゼ阻害剤、抗線維化剤） ・特発性肺線維症の用途別市場規模2014-2019 （病院、診療所、外来手術センター、学術研究機関） ・特発性肺線維症の北米市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症の中国市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症の日本国内市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症の東南アジア市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症のインド市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （MediciNova、Boehringer Ingelheim、F. Hoffmann-La Roche、FibroGen、Promedior、Merck、Galapagos、Prometic Life Sciences、Cipla） ・特発性肺線維症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.An increase in the incidence and prevalence of fibrotic diseases is the primary driver for the growth of this market. Idiopathic pulmonary fibrosis most commonly affects middle-aged to older adults and is characterized by the scarring of lung tissues. In older people, these scars tend to build up and affect the normal functioning of lungs. Thus, an increase in aging population leads to increased prevalence of the disease, which in turn results in market growth during the predicted period.
In 2018, the global Idiopathic Pulmonary Fibrosis market size was 1620 million US$ and it is expected to reach 3940 million US$ by the end of 2025, with a CAGR of 11.7% during 2019-2025.
This report focuses on the global Idiopathic Pulmonary Fibrosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Idiopathic Pulmonary Fibrosis development in United States, Europe and China.
The key players covered in this study
MediciNova
Boehringer Ingelheim
F. Hoffmann-La Roche
FibroGen
Promedior
Merck
Galapagos
Prometic Life Sciences
Cipla
Market segment by Type, the product can be split into
Systemic Corticosteroids
Immunosuppressant Drugs
Tyrosine Kinase Inhibitors
Antifibrotic Agents
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Academic and Research Organizations
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Idiopathic Pulmonary Fibrosis status, future forecast, growth opportunity, key market and key players.
To present the Idiopathic Pulmonary Fibrosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Idiopathic Pulmonary Fibrosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Idiopathic Pulmonary Fibrosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Systemic Corticosteroids
1.4.3 Immunosuppressant Drugs
1.4.4 Tyrosine Kinase Inhibitors
1.4.5 Antifibrotic Agents
1.5 Market by Application
1.5.1 Global Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Academic and Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Idiopathic Pulmonary Fibrosis Market Size
2.2 Idiopathic Pulmonary Fibrosis Growth Trends by Regions
2.2.1 Idiopathic Pulmonary Fibrosis Market Size by Regions (2014-2025)
2.2.2 Idiopathic Pulmonary Fibrosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Idiopathic Pulmonary Fibrosis Market Size by Manufacturers
3.1.1 Global Idiopathic Pulmonary Fibrosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Idiopathic Pulmonary Fibrosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Idiopathic Pulmonary Fibrosis Market Concentration Ratio (CR5 and HHI)
3.2 Idiopathic Pulmonary Fibrosis Key Players Head office and Area Served
3.3 Key Players Idiopathic Pulmonary Fibrosis Product/Solution/Service
3.4 Date of Enter into Idiopathic Pulmonary Fibrosis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019)
4.2 Global Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019)
5 United States
5.1 United States Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
5.2 Idiopathic Pulmonary Fibrosis Key Players in United States
5.3 United States Idiopathic Pulmonary Fibrosis Market Size by Type
5.4 United States Idiopathic Pulmonary Fibrosis Market Size by Application
6 Europe
6.1 Europe Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
6.2 Idiopathic Pulmonary Fibrosis Key Players in Europe
6.3 Europe Idiopathic Pulmonary Fibrosis Market Size by Type
6.4 Europe Idiopathic Pulmonary Fibrosis Market Size by Application
7 China
7.1 China Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
7.2 Idiopathic Pulmonary Fibrosis Key Players in China
7.3 China Idiopathic Pulmonary Fibrosis Market Size by Type
7.4 China Idiopathic Pulmonary Fibrosis Market Size by Application
8 Japan
8.1 Japan Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
8.2 Idiopathic Pulmonary Fibrosis Key Players in Japan
8.3 Japan Idiopathic Pulmonary Fibrosis Market Size by Type
8.4 Japan Idiopathic Pulmonary Fibrosis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
9.2 Idiopathic Pulmonary Fibrosis Key Players in Southeast Asia
9.3 Southeast Asia Idiopathic Pulmonary Fibrosis Market Size by Type
9.4 Southeast Asia Idiopathic Pulmonary Fibrosis Market Size by Application
10 India
10.1 India Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
10.2 Idiopathic Pulmonary Fibrosis Key Players in India
10.3 India Idiopathic Pulmonary Fibrosis Market Size by Type
10.4 India Idiopathic Pulmonary Fibrosis Market Size by Application
11 Central & South America
11.1 Central & South America Idiopathic Pulmonary Fibrosis Market Size (2014-2019)
11.2 Idiopathic Pulmonary Fibrosis Key Players in Central & South America
11.3 Central & South America Idiopathic Pulmonary Fibrosis Market Size by Type
11.4 Central & South America Idiopathic Pulmonary Fibrosis Market Size by Application
12 International Players Profiles
12.1 MediciNova
12.1.1 MediciNova Company Details
12.1.2 Company Description and Business Overview
12.1.3 Idiopathic Pulmonary Fibrosis Introduction
12.1.4 MediciNova Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.1.5 MediciNova Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Company Details
12.2.2 Company Description and Business Overview
12.2.3 Idiopathic Pulmonary Fibrosis Introduction
12.2.4 Boehringer Ingelheim Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.2.5 Boehringer Ingelheim Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Idiopathic Pulmonary Fibrosis Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 FibroGen
12.4.1 FibroGen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Idiopathic Pulmonary Fibrosis Introduction
12.4.4 FibroGen Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.4.5 FibroGen Recent Development
12.5 Promedior
12.5.1 Promedior Company Details
12.5.2 Company Description and Business Overview
12.5.3 Idiopathic Pulmonary Fibrosis Introduction
12.5.4 Promedior Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.5.5 Promedior Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Idiopathic Pulmonary Fibrosis Introduction
12.6.4 Merck Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Galapagos
12.7.1 Galapagos Company Details
12.7.2 Company Description and Business Overview
12.7.3 Idiopathic Pulmonary Fibrosis Introduction
12.7.4 Galapagos Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.7.5 Galapagos Recent Development
12.8 Prometic Life Sciences
12.8.1 Prometic Life Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Idiopathic Pulmonary Fibrosis Introduction
12.8.4 Prometic Life Sciences Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.8.5 Prometic Life Sciences Recent Development
12.9 Cipla
12.9.1 Cipla Company Details
12.9.2 Company Description and Business Overview
12.9.3 Idiopathic Pulmonary Fibrosis Introduction
12.9.4 Cipla Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)
12.9.5 Cipla Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Idiopathic Pulmonary Fibrosis Key Market Segments
Table Key Players Idiopathic Pulmonary Fibrosis Covered
Table Global Idiopathic Pulmonary Fibrosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Market Size Market Share by Type 2014-2025
Figure Systemic Corticosteroids Figures
Table Key Players of Systemic Corticosteroids
Figure Immunosuppressant Drugs Figures
Table Key Players of Immunosuppressant Drugs
Figure Tyrosine Kinase Inhibitors Figures
Table Key Players of Tyrosine Kinase Inhibitors
Figure Antifibrotic Agents Figures
Table Key Players of Antifibrotic Agents
Table Global Idiopathic Pulmonary Fibrosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Academic and Research Organizations Case Studies
Figure Idiopathic Pulmonary Fibrosis Report Years Considered
Table Global Idiopathic Pulmonary Fibrosis Market Size 2014-2025 (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Market Size by Regions 2014-2025 (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Market Size by Regions 2014-2019 (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Market Share by Regions 2014-2019
Figure Global Idiopathic Pulmonary Fibrosis Market Share by Regions 2014-2019
Figure Global Idiopathic Pulmonary Fibrosis Market Share by Regions 2019
Table Market Top Trends
Table Global Idiopathic Pulmonary Fibrosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Market Share by Manufacturers (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Market Share by Manufacturers in 2018
Table Global Idiopathic Pulmonary Fibrosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Idiopathic Pulmonary Fibrosis Product/Solution/Service
Table Date of Enter into Idiopathic Pulmonary Fibrosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Market Size Share by Type (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Market Size Market Share by Type (2014-2019)
Table Global Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Market Size Share by Application (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Market Size Market Share by Application (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Revenue Market Share by Application in 2018
Figure United States Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table United States Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table United States Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table United States Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table United States Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table United States Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table United States Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Figure Europe Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table Europe Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table Europe Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table Europe Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table Europe Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Figure China Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table China Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table China Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table China Idiopathic Pulmonary Fibrosis Market Size by Type (2014-20189) (Million US$)
Table China Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table China Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table China Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Figure Japan Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table Japan Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table Japan Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table Japan Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table Japan Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Figure India Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table India Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table India Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table India Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table India Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table India Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table India Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Figure Central & South America Idiopathic Pulmonary Fibrosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Idiopathic Pulmonary Fibrosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Idiopathic Pulmonary Fibrosis Market Share (2018-2019)
Table Central & South America Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Idiopathic Pulmonary Fibrosis Market Share by Type (2014-2019)
Table Central & South America Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Idiopathic Pulmonary Fibrosis Market Share by Application (2014-2019)
Table MediciNova Company Details
Table MediciNova Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019) (Million US$)
Figure MediciNova Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table MediciNova Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table FibroGen Company Details
Table FibroGen Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure FibroGen Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table FibroGen Recent Development
Table Promedior Company Details
Table Promedior Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure Promedior Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table Promedior Recent Development
Table Merck Company Details
Table Merck Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table Merck Recent Development
Table Galapagos Company Details
Table Galapagos Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure Galapagos Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table Galapagos Recent Development
Table Prometic Life Sciences Company Details
Table Prometic Life Sciences Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure Prometic Life Sciences Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table Prometic Life Sciences Recent Development
Table Cipla Company Details
Table Cipla Revenue in Idiopathic Pulmonary Fibrosis Business (2014-2019)(Million US$)
Figure Cipla Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Business (2014-2019)
Table Cipla Recent Development
Table Global Idiopathic Pulmonary Fibrosis Market Size by Regions (Million US$) 2019-2025
Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Regions (2019-2025)
Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Regions in 2025
Figure United States Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Figure China Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Figure India Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Idiopathic Pulmonary Fibrosis Market Size Forecast (2019-2025)(Million USD)
Table Global Idiopathic Pulmonary Fibrosis Market Size by Product (2019-2025) (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Market Size by Product (2019-2025)
Figure Global Idiopathic Pulmonary Fibrosis Market Size by Product in 2025
Table Global Idiopathic Pulmonary Fibrosis Market Size by Application (2019-2025) (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Market Size by Application (2019-2025)
Figure Global Idiopathic Pulmonary Fibrosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
肺薬の世界市場：インサイト・予測 The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or in…- 慢性特発性骨髄線維症の世界市場：市場規模・現状・予測 Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…
- 皮膚線維症の治療の世界市場：市場規模・現状・予測 Cutaneous fibrosis is the accumulation of extracellular matrix (ECM) components in the dermis, leading to compromised function and altered architecture of the dermis. Development of fibrosis occurs naturally during scar formation in wound repair or is a pathological process in pro-fibrotic diseases.…
- 呼吸器用薬の世界市場：市場規模・現状・予測 In 2018, the global Respiratory Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 4.1% during 2019-2025. This report focuses on the global Respiratory Drugs status, future forecast, growth opportunity, key market and key players. The s…
- 嚢胞性線維症（粘液嚢胞症）検査の世界市場：市場規模・現状・予測 Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thi…